Nora Schmit (PhD Candidate, Imperial College London, UK)
Nora Schmit is an epidemiologist and currently a PhD candidate at the Department of Infectious Disease Epidemiology. Her work focuses on the mathematical modelling of hepatitis B transmission dynamics and natural history in sub-Saharan Africa, primarily in The Gambia. In her modelling analysis, she uses data from the PROLIFICA study to investigate potential strategies for the implementation of a hepatitis B screening and treatment programme.
Jin Kim (Clinical Research Fellow, Imperial College London, UK)
Jin Kim is a clinical research fellow at St Mary’s Hospital. He has been involved in global health projects relating to chronic liver diseases and communicable infections in resource-limited regions, with ongoing work to improve the care cascade of people living with chronic viral hepatitis in Tanzania.
Damien Leith (Registrar, Glasgow, UK)
Damien Leith is a gastroenterology & hepatology registrar based in Glasgow, Scotland. Damien worked with the PROLIFICA group in The Gambia from September 2018 to July 2019, assisting with clinical assessment and data collection for the MATCH-B study. He is currently working with the group on the Occult Hepatitis B systematic review and hopes to undertake a PhD with Prof Lemoine in the future.
Liem Binh Luong (PhD Candidate, Pasteur Institute, Paris, France)
Dr Liem Binh Luong Nguyen (MD, MPH), is an infectious disease specialist which research focuses on modelling and cost-effectiveness analysis of prevention interventions. He is currently working on a model-based analysis of treatment allocation strategies for HBV chronic infection in The Gambia.
Damien Cohen is a project manager for the ANRS and a PhD candidate in virology at the Cancer Research Center of Lyon (CRCL). For several years now he has been working on the PROLIFICA project as part of his thesis. He is particularly interested in measuring risk factors associated with the development and progression of the liver disease such as viral variants and aflatoxin B1 (AFB1) exposure. His missions are tightly intertwined with the activities of the International Agency for Research on Cancer (IARC), in particular regarding the screen for AFB1 exposure.
Rayana Toyé (Iressef, Sénégal)
Rayana Toyé is a PhD student in Molecular Biology at the Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation (Iressef). After graduating from high school in Niger where she is from, she completed her master’s degree in Biology in Burkina Faso with internships at the Centre Muraz research institute. She is currently working on the ANRS 12357 project on Senegalese patients from Prolifica. The frame of her thesis was developed at Iressef in Dakar and included a fourteen-month stay at Inserm U1052 in Lyon. Her research focuses on HBV variants and biomarkers related to hepatocellular carcinoma (HCC) in hepatitis B virus (HBV)-infected patients, such as expression of mi-RNAs and TP53 mutation related to exposure to aflatoxin B1 (AFB1). For this latter part, she carried out periods of work at the International Agency for Research on Cancer (IARC) whose activities are strongly linked to the detection of exposure to AFB1. She also worked on the molecular characterization of HBV in Senegalese HIV-infected children.
Kyoko Yoshido (Tokyo Medical and Dental University, Japan)
Kyoko Yoshida is a medical student of Tokyo Medical and Dental University in Japan. She worked with PROLIFICA in Imperial College London in 2018 and MRC Unit the Gambia in 2019. Even her returning back to Japan, she keeps on working with the team, participating in some systematic reviews.